Replies to post #121295 on Biotech Values

[DewDiligence]

what does [Teva’s CP rejection] mean to MNTA's chances of getting M-Copaxone approval in 2011?

It’s certainly not bearish for MNTA, but it’s probably not bullish either. For now, I’m keeping the handicapping numbers in #msg-60836359 unchanged.